Plain-English translation of NCT06427876 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is tracking how well Fasenra® (an injectable asthma medication) works and how safe it is when used in real-world settings in children with severe asthma. Researchers want to understand any unexpected side effects that might happen and how well the medication controls asthma symptoms and lung function in children aged 6 to under 15 years old.
This medication is already approved and being used, but the research team needs to gather more information about its long-term safety and effectiveness in children in Japan. This helps make sure the treatment continues to be as safe and effective as possible for young patients with hard-to-control asthma.
You would receive the injectable medication as prescribed by your doctor and attend follow-up visits so researchers can monitor how well your asthma is controlled and check your lung function. The study team will also watch for any side effects or unexpected reactions to the medication during these visits. This is an observational study, meaning researchers are mainly tracking your progress rather than comparing you to other treatment groups.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Japan